Phagenyx

Phagenyx company information, Employees & Contact Information

Explore related pages

Related company profiles:

Welcome to the Phagenesis LinkedIn page!  At Phagenesis, we are dedicated to transforming the way dysphagia is treated. Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide. We believe that everyone deserves the ability to enjoy their meals and live their lives to the fullest, which is why we have developed the Phagenyx - a revolutionary product that uses Pharyngeal Electrical Stimulation (PES) to treat dysphagia.  The Phagenyx is a simple, non-invasive device that stimulates the nerves in the pharynx, helping patients regain control of their swallowing function. Our product has been rigorously tested in clinical trials and has been shown to significantly improve swallowing ability in patients with dysphagia.  As a company, we are committed to advancing the field of dysphagia care through innovative technology and evidence-based practices. We work closely with healthcare providers and patients to ensure that our product meets the highest standards of safety and efficacy.  We are proud to be changing the paradigm of dysphagia care, and we invite you to join us in our mission to improve the lives of millions of people around the world. Follow our page to stay up-to-date on the latest news and developments in dysphagia care, and to learn more about the Phagenyx and how it is helping patients overcome dysphagia.
Looking for a particular Phagenyx employee's phone or email?

Phagenyx Questions

News

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing - PR Newswire

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing PR Newswire

Arizona chef able to swallow again thanks to new therapy - Banner Health

Arizona chef able to swallow again thanks to new therapy Banner Health

Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control - NeuroNews International

Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control NeuroNews International

Nestle Health Science agrees to conditional purchase of Phagenesis - PlasticsToday

Nestle Health Science agrees to conditional purchase of Phagenesis PlasticsToday

Phagenesis Launches Phagenyx Neurostimulation System in the U.S. - BioSpace

Phagenesis Launches Phagenyx Neurostimulation System in the U.S. BioSpace

Phagenesis sucks in $42M for ‘game changing’ dysphagia device - BioWorld MedTech

Phagenesis sucks in $42M for ‘game changing’ dysphagia device BioWorld MedTech

Advising Phagenesis on its US$42 million Series D financing round - Taylor Wessing

Advising Phagenesis on its US$42 million Series D financing round Taylor Wessing

Neurostim company Phagenesis picks new CEO - MassDevice

Neurostim company Phagenesis picks new CEO MassDevice

EQT Life Sciences and Sectoral lead $42M investment in medtech Phagenesis - Tech.eu

EQT Life Sciences and Sectoral lead $42M investment in medtech Phagenesis Tech.eu

Nestle to buy medical device company Phagenesis in stages - Reuters

Nestle to buy medical device company Phagenesis in stages Reuters

UK: Phagenesis appoints Chad Hoskins as CEO - Investors in Healthcare

UK: Phagenesis appoints Chad Hoskins as CEO Investors in Healthcare

Report: Pharyngeal neurostim company Phagenesis raises $42M - MassDevice

Report: Pharyngeal neurostim company Phagenesis raises $42M MassDevice

Largest real-world study of Phagenyx® demonstrates significant benefits of treatment in patients with unsafe swallowing (neurogenic dysphagia) resulting from multiple causes - PR Newswire

Largest real-world study of Phagenyx® demonstrates significant benefits of treatment in patients with unsafe swallowing (neurogenic dysphagia) resulting from multiple causes PR Newswire

Phagenesis raises £33m for device treating effects of brain injury - UKTN

Phagenesis raises £33m for device treating effects of brain injury UKTN

University leaps up global innovation list - The University of Manchester

University leaps up global innovation list The University of Manchester

Phagenesis wins FDA breakthrough nod for Phagenyx System for restoring swallowing - MassDevice

Phagenesis wins FDA breakthrough nod for Phagenyx System for restoring swallowing MassDevice

Phagenesis launches Phagenyx neurostim system in U.S. - MassDevice

Phagenesis launches Phagenyx neurostim system in U.S. MassDevice

Top Phagenyx Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant